Does Kaiser Permanente Cover Cialis (Tadalafil)? A Complete 2025 Guide

What Kaiser Permanente's Formulary Actually Says About Tadalafil

Kaiser Permanente covers generic tadalafil across all of its eight regional health plans, but brand-name Cialis is classified as non-formulary or requires step therapy in most regions. Generic tadalafil became available in the United States in September 2018 after Eli Lilly's patent exclusivity expired, and most large insurers including Kaiser shifted their formularies to the generic within one plan year.

How the Formulary Tier System Works

Kaiser uses a tiered formulary, typically spanning four to five tiers. Generic tadalafil sits on Tier 2 (preferred generic) or Tier 3 (non-preferred generic) depending on the specific regional plan. Tier 2 copays at Kaiser pharmacies generally run $10, $20 per 30-day supply, while Tier 3 copays run $25, $40. Brand-name Cialis, when it appears at all, lands on Tier 4 or Tier 5, meaning a member pays 30 to 50% coinsurance after the deductible, which can translate to $300, $500 per month.

The FDA approved tadalafil for erectile dysfunction under the brand name Cialis on November 21, 2003 [1], and the generic version carries the same approval. Kaiser's pharmacy and therapeutics committees review formulary placement annually, so tier assignments can shift between January 1 plan renewals.

Covered Indications vs. Off-Label Use

Kaiser's coverage decision depends heavily on the documented indication:

• Erectile dysfunction (ED). Covered with a valid diagnosis code (ICD-10 N52.x). Prior authorization is required in most Kaiser regions.
• Benign prostatic hyperplasia (BPH). Tadalafil 5 mg daily is FDA-approved for BPH [2] and typically covered with fewer prior authorization hurdles than the ED indication.
• Pulmonary arterial hypertension (PAH). Tadalafil under the brand name Adcirca (20 mg tablets) carries a separate FDA approval for PAH [3] and is covered under different formulary rules, usually at specialty-drug tier with separate cost-sharing.
• Off-label uses. Any off-label prescription (for example, Raynaud's phenomenon) will likely require a formulary exception request and documented medical necessity.

Erectile dysfunction affects approximately 30 million men in the United States, according to the National Institute of Diabetes and Digestive and Kidney Diseases [4]. That prevalence makes ED one of the more common reasons Kaiser members seek tadalafil coverage.

Prior Authorization Requirements at Kaiser

Prior authorization (PA) is required for tadalafil prescribed for erectile dysfunction at most Kaiser regional plans. The PA process asks the prescribing physician to document the diagnosis, confirm that cardiovascular contraindications have been evaluated, and in some plans confirm that the member has tried sildenafil first.

What the PA Form Asks

A standard Kaiser PA request for tadalafil typically includes:

1. ICD-10 diagnosis code confirming ED or BPH
2. Member's current cardiovascular medications (nitrate use is an absolute contraindication) [5]
3. Documentation that sildenafil was trialed and either failed or caused intolerable adverse effects, if step therapy applies
4. Prescriber attestation that the dose requested (2.5 mg, 5 mg, 10 mg, or 20 mg) matches the clinical indication

Step therapy requirements are not universal across Kaiser regions. Kaiser Northern California, Kaiser Southern California, Kaiser Mid-Atlantic, and Kaiser Northwest each manage their own formularies. A member in one region may face a sildenafil step, while a member in another region may receive tadalafil approval on the first request.

How Long PA Approval Takes

Standard prior authorization decisions at Kaiser take up to 72 hours for non-urgent cases. Urgent requests, defined as situations where a delay would seriously harm the member's health, must be resolved within 24 hours under California law and comparable state statutes in other Kaiser service areas [6]. Once approved, PA authorization typically covers a 12-month supply period before requiring renewal.

What Happens If PA Is Denied

A denial does not close the door. Kaiser members have the right to file an internal appeal within 30 days of receiving the denial notice. If the internal appeal fails, members in California can request an Independent Medical Review through the Department of Managed Health Care, a process that has a 45-day resolution window for standard reviews. The American Urological Association (AUA) 2018 guideline on erectile dysfunction states that PDE5 inhibitors "are recommended as first-line therapy for ED in the absence of contraindications" [7], which can serve as supporting documentation in an appeal.

How Much Does Tadalafil Cost at Kaiser Pharmacies?

Generic tadalafil costs vary by dose, quantity, and plan tier. The following estimates reflect Kaiser pharmacy pricing for members who have met their deductible:

| Dose | Days' Supply | Estimated Copay (Tier 2) | Estimated Copay (Tier 3) | |------|-------------|--------------------------|--------------------------| | 5 mg daily | 30 tablets | $10, $20 | $25, $35 | | 10 mg as-needed | 6 tablets | $10, $15 | $20, $30 | | 20 mg as-needed | 6 tablets | $12, $20 | $25, $40 |

Members who have not yet met their annual deductible pay the plan's contracted rate for the drug, which for generic tadalafil typically runs $30, $80 per 30-day supply at Kaiser's pharmacy, well below the retail cash price of $150, $250 that non-insured patients pay at commercial pharmacies.

The cost picture improves further with Kaiser's Mail Order Pharmacy, which generally offers a 90-day supply for roughly twice the 30-day copay, effectively giving members one month free on many generic tiers.

Tadalafil 5 mg Daily vs. 10/20 mg As-Needed: Which Does Kaiser Prefer?

Kaiser's clinical guidelines align with the AUA's recommendation that either the on-demand or daily dosing strategy is appropriate depending on sexual activity frequency and patient preference [7]. From a formulary standpoint, tadalafil 5 mg daily may receive smoother PA approval when the documented indication includes BPH alongside ED, because the 5 mg daily dose is FDA-labeled for both conditions simultaneously [2].

Clinical Evidence for Daily Dosing

A 12-week randomized controlled trial published in the Journal of Urology (N=268) found that tadalafil 5 mg once daily produced significant improvement in International Index of Erectile Function (IIEF) scores compared to placebo (mean IIEF-EF domain score improvement: 6.0 vs. 1.2, P<0.001) [8]. Daily dosing also normalized penile endothelial function over time in men with vasculogenic ED, a finding that on-demand dosing did not replicate to the same degree.

Clinical Evidence for On-Demand Dosing

The key Phase III trial for tadalafil 20 mg on-demand (N=348) reported that 81% of sexual intercourse attempts were successful in the tadalafil group versus 35% in the placebo group [9]. That separation supports insurance coverage because it demonstrates clear clinical benefit, an argument useful in PA appeals.

BPH Coverage: A Simpler Path to Tadalafil

Benign prostatic hyperplasia affects roughly 50% of men by age 60 and up to 90% of men by age 85, according to data from the National Institute on Aging [10]. Because tadalafil 5 mg daily carries an explicit FDA label for BPH, men who have both ED and lower urinary tract symptoms often find that the BPH indication generates faster PA approval with less documentation burden.

A Kaiser physician can prescribe tadalafil 5 mg daily citing the BPH indication, and it simultaneously addresses erectile dysfunction. This dual benefit is recognized in the AUA/SUFU 2021 guideline on benign prostatic hyperplasia, which lists tadalafil as an option for men with both LUTS and ED who desire a single oral agent [11].

How to Get Kaiser to Cover Tadalafil: A Step-by-Step Approach

Step 1: Schedule the Right Appointment

Book an appointment with your Kaiser primary care physician or a Kaiser urologist. Telehealth video visits through the Kaiser app can initiate prescriptions, but complex PA requests may be handled more efficiently in-person. Be direct: tell the provider you want to discuss erectile dysfunction and any urinary symptoms, because documented BPH symptoms strengthen the coverage case.

Step 2: Get a Formal Diagnosis Documented

The ICD-10 code must appear in your medical record before the pharmacy will process a PA. Organic ED (N52.1), psychogenic ED (F52.21), and BPH (N40.1 with LUTS) are the three most common qualifying codes. Your provider should enter the diagnosis into Kaiser's Epic-based health record during the visit.

Step 3: Ask the Provider to Submit the PA Simultaneously

Kaiser's electronic prescribing system can attach a PA request at the time of prescribing. Ask your provider to submit it electronically rather than by fax, which reduces processing time by 24 to 48 hours based on Kaiser's own pharmacy services documentation.

Step 4: Monitor the PA Status

Kaiser members can track PA status through kp.org or the Kaiser Permanente app. You will receive a secure message when a decision is made. If you have not heard within 72 hours for a standard request, call Kaiser's Pharmacy Advice line directly.

Step 5: Appeal If Denied

Pull the denial letter, note the specific reason, and gather supporting clinical documentation. The AUA guideline statement [7] is a good anchor. A 2020 systematic review in the Journal of Sexual Medicine confirmed that PDE5 inhibitors including tadalafil have a favorable safety profile and high efficacy across age groups and comorbidity categories [12], which further supports medical necessity arguments.

Does Kaiser Cover Brand-Name Cialis?

Brand-name Cialis is almost never covered under standard Kaiser formularies as of 2025. Eli Lilly's branded product commands a retail price of approximately $400, $450 per 30 tablets of 5 mg, and generic tadalafil is therapeutically identical. The FDA's Orange Book confirms that all approved generic tadalafil formulations are rated "AB," meaning they are bioequivalent to the reference listed drug [13].

Members who specifically want brand Cialis for a non-clinical reason (packaging preference, for example) will pay full non-formulary cost. There is no clinical or regulatory basis for preferring branded Cialis over generic tadalafil, and Kaiser's formulary committee reflects this position.

Cardiovascular Safety and Why Kaiser Requires Careful Screening

Tadalafil, like all PDE5 inhibitors, causes vasodilation that can interact dangerously with nitrate medications. The FDA label carries a contraindication for concurrent use with any organic nitrate in any form [1]. Kaiser's prior authorization process partly exists to ensure that a physician has screened for nitrate use, hypotension, and severe hepatic impairment before the drug is dispensed.

Key Safety Data

The cardiovascular safety of tadalafil was evaluated in the CONFIRM-1 and CONFIRM-2 trials, which together enrolled over 1,000 men with ED and found no increase in myocardial infarction rates compared to placebo [14]. The Princeton Consensus Panel III (2012) stratified sexual activity risk and concluded that most men with stable cardiovascular disease fall into the low-risk category and can safely use PDE5 inhibitors without additional cardiac workup [15].

A baseline testosterone level is not required before prescribing tadalafil, but Kaiser providers often check it because hypogonadism is present in 10 to 15% of men presenting with ED, and testosterone replacement can improve PDE5 inhibitor response in hypogonadal men [16]. An American Urological Association position statement notes that "evaluation of testosterone levels should be considered in men with ED, particularly those with decreased libido" [7].

Alternatives Kaiser Covers If Tadalafil Is Denied

If tadalafil is denied and the appeal fails, Kaiser formularies include several alternatives:

• Sildenafil (generic Viagra). Tier 1 or Tier 2 at most Kaiser plans. Usually the least expensive PDE5 inhibitor option at $8, $15 per 30-day supply of 25 mg or 50 mg tablets. Clinical efficacy is comparable: the original sildenafil Phase III trials showed 69% improvement in IIEF scores vs. 22% placebo [17].
• Vardenafil (generic Levitra). Tier 2 or Tier 3. Similar mechanism and contraindication profile. Less studied than sildenafil in long-term cardiovascular outcomes.
• Avanafil (Stendra). Typically Tier 3 or non-formulary. Faster onset (15 minutes vs. 30 to 60 minutes for tadalafil) but more expensive.
• Vacuum erection devices. Covered under Kaiser's durable medical equipment benefit with a physician order.
• Penile injection therapy (alprostadil). Covered under the pharmacy benefit. The Caverject Impulse formulation is FDA-approved and appears on Kaiser formularies as a Tier 2 or Tier 3 drug [18].

Sildenafil is the most common first-line prescription under Kaiser's step therapy protocol, precisely because it is cheap and well-studied. If you can tolerate sildenafil, Kaiser will likely approve it on the first request without a PA in many regions.

Special Populations and Coverage Nuances

Men Over 65 on Medicare Advantage Through Kaiser

Kaiser Medicare Advantage plans (Senior Advantage) follow Medicare Part D formulary rules. Traditional Medicare Part D does not cover drugs prescribed "for the treatment of sexual or erectile dysfunction" by statute [19]. However, when tadalafil is prescribed specifically for BPH, it may be covered under Part D because the statutory exclusion is diagnosis-specific. Members should ask their Kaiser pharmacist to confirm the specific indication on the prescription before processing.

Men With Diabetes

Erectile dysfunction is present in 35 to 75% of men with diabetes, according to data published in Diabetes Care [20]. Kaiser's diabetes care protocols routinely screen for ED, making it easier to document the diagnosis. The American Diabetes Association Standards of Care note that ED should be assessed and treated in men with diabetes [21], which gives Kaiser providers clear clinical grounding to prescribe tadalafil and support PA approval.

Men Post-Prostatectomy

Nerve-sparing radical prostatectomy still results in ED in 25 to 75% of men depending on surgical technique and pre-operative function. Tadalafil 5 mg daily has been studied specifically in post-prostatectomy populations: a 52-week trial (N=139) showed that daily tadalafil improved spontaneous erection recovery versus placebo (35% vs. 15% achieving normal EF domain scores, P<0.001) [22]. Kaiser urologists familiar with this data can cite it when submitting PA requests for post-prostatectomy patients.

Using Kaiser's Telehealth Services to Start the Process

Kaiser's on-demand video visits are available 24/7 through the Kaiser Permanente app. A physician on a video visit can document ED, order labs, and submit a tadalafil prescription with a simultaneous PA request in a single session. The visit copay is typically $0, $49 depending on plan, which is often less than a traditional office visit copay.

For members who feel uncomfortable discussing ED in person, the video visit pathway removes a practical barrier. The provider still must complete the same clinical documentation, but the interaction happens from the privacy of the member's home.

Frequently Asked Questions